Literature DB >> 23290051

Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells.

Eriko Kudo1, Manabu Taura, Kouki Matsuda, Masako Shimamoto, Ryusho Kariya, Hiroki Goto, Shinichiro Hattori, Shinya Kimura, Seiji Okada.   

Abstract

The anti-HIV-1 activity of GUT-70, a natural product derived from the stem bark of Chlophyllum brasiliense, was evaluated. GUT-70 inhibited HIV-1 replication in both acutely and chronically infected cells through suppression of NF-κB. Our results strengthen the idea that NF-κB pathway is one of the potential targets to control HIV-1 replication and that GUT-70 could serve as a lead compound to develop novel therapeutic agents against HIV-1 infection.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23290051     DOI: 10.1016/j.bmcl.2012.12.034

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.

Authors:  Manabu Taura; Eriko Kudo; Ryusho Kariya; Hiroki Goto; Kouki Matsuda; Shinichiro Hattori; Kulthida Vaeteewoottacharn; Fiona McDonald; Mary Ann Suico; Tsuyoshi Shuto; Hirofumi Kai; Seiji Okada
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

2.  The validation of Calophyllum brasiliense ("guanandi") uses in Brazilian traditional medicine as analgesic by in vivo antinociceptive evaluation and its chemical analysis.

Authors:  Luiz Carlos Klein-Júnior; Daniele Zambiasi; Giovana Rocha Salgado; Franco Delle Monache; Valdir Cechinel Filho; Fátima de Campos Buzzi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-08       Impact factor: 3.000

3.  Tale of Viruses in Male Infertility.

Authors:  Shreya Das; Arunima Mondal; Jayeeta Samanta; Santanu Chakraborty; Arunima Sengupta
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  Polyphenols and their potential role to fight viral diseases: An overview.

Authors:  María Fernanda Montenegro-Landívar; Paulina Tapia-Quirós; Xanel Vecino; Mònica Reig; César Valderrama; Mercè Granados; José Luis Cortina; Javier Saurina
Journal:  Sci Total Environ       Date:  2021-08-19       Impact factor: 7.963

Review 5.  CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy.

Authors:  Fedora Grande; Maria Antonietta Occhiuzzi; Bruno Rizzuti; Giuseppina Ioele; Michele De Luca; Paola Tucci; Valentina Svicher; Stefano Aquaro; Antonio Garofalo
Journal:  Molecules       Date:  2019-02-02       Impact factor: 4.411

6.  A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis.

Authors:  Asma Farjallah; Laurent R Chiarelli; Martin Forbak; Giulia Degiacomi; Mathieu Danel; Fernanda Goncalves; Chantal Carayon; Cendrine Seguin; Marco Fumagalli; Monika Záhorszká; Elodie Vega; Souhir Abid; Anna Grzegorzewicz; Mary Jackson; Antonio Peixoto; Jana Korduláková; Maria Rosalia Pasca; Christian Lherbet; Stefan Chassaing
Journal:  ACS Infect Dis       Date:  2021-02-22       Impact factor: 5.084

Review 7.  Herbal plants and plant preparations as remedial approach for viral diseases.

Authors:  Rajesh Kumar Ganjhu; Piya Paul Mudgal; Hindol Maity; Deepu Dowarha; Santhosha Devadiga; Snehlata Nag; Govindakarnavar Arunkumar
Journal:  Virusdisease       Date:  2015-09-03

Review 8.  Antiviral natural products and herbal medicines.

Authors:  Liang-Tzung Lin; Wen-Chan Hsu; Chun-Ching Lin
Journal:  J Tradit Complement Med       Date:  2014-01

9.  Anti-HIV Activity of Ocimum labiatum Extract and Isolated Pheophytin-a.

Authors:  Petrina Kapewangolo; Martha Kandawa-Schulz; Debra Meyer
Journal:  Molecules       Date:  2017-11-06       Impact factor: 4.411

Review 10.  The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases.

Authors:  Pardis Mohammadi Pour; Sajad Fakhri; Sedigheh Asgary; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.